| 000 | 01859 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517020026.0 | ||
| 264 | 0 | _c20151215 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1573-7241 | ||
| 024 | 7 |
_a10.1007/s10557-015-6572-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEschalier, Romain | |
| 245 | 0 | 0 |
_aImpact of clinical characteristics and management on the prognosis of unselected heart failure patients. _h[electronic resource] |
| 260 |
_bCardiovascular drugs and therapy _cFeb 2015 |
||
| 300 |
_a89-98 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aPrognosis |
| 700 | 1 | _aChenaf, Chouki | |
| 700 | 1 | _aMulliez, Aurélien | |
| 700 | 1 | _aYalioua, Arab | |
| 700 | 1 | _aClerfond, Guillaume | |
| 700 | 1 | _aAuthier, Nicolas | |
| 700 | 1 | _aVorilhon, Charles | |
| 700 | 1 | _aCitron, Bernard | |
| 700 | 1 | _aPereira, Bruno | |
| 700 | 1 | _aJean, Frédéric | |
| 700 | 1 | _aSouteyrand, Géraud | |
| 700 | 1 | _aMotreff, Pascal | |
| 700 | 1 | _aEschalier, Alain | |
| 700 | 1 | _aLusson, Jean-René | |
| 773 | 0 |
_tCardiovascular drugs and therapy _gvol. 29 _gno. 1 _gp. 89-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10557-015-6572-y _zAvailable from publisher's website |
| 999 |
_c24641387 _d24641387 |
||